Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06701968
What this trial is testing

Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease

Who this might be right for
Coronary DiseaseCoronary ArteriosclerosisMyocardial Infarction+3 more
Uppsala University 150
Post-approval studies (Phase 4)Study completedNCT00760513
What this trial is testing

Treatment of Non Alcoholic Fatty Liver Disease With n-3 Fatty Acids

Who this might be right for
Non-Alcoholic Fatty Liver Disease
University Hospital Southampton NHS Foundation Trust 103
Post-approval studies (Phase 4)Study completedNCT01006889
What this trial is testing

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 24
Testing effectiveness (Phase 2)Study completedNCT00819338
What this trial is testing

The Effect of n-3 Polyunsaturated Fatty Acid Supplements in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
University of Nottingham 58
Testing effectiveness (Phase 2)Looking for participantsNCT07527910
What this trial is testing

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 204
Testing effectiveness (Phase 2)Looking for participantsNCT04501406
What this trial is testing

Low-Dose Pioglitazone in Patients With NASH (AIM 2)

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida 166
Early research (Phase 1)UnknownNCT05686174
What this trial is testing

Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver Disease
National Taiwan University Hospital 30
Not applicableNot Yet RecruitingNCT07570810
What this trial is testing

Efficacy, Safety, and Tolerability of CS0159 Combined With Semaglutide in MAFLD Patients With Obesity and T2DM

Who this might be right for
Type 2 DiabetesObesityNon-alcoholic Fatty Liver Disease
Shanghai Jiao Tong University School of Medicine 30
Not applicableStudy completedNCT07837323
What this trial is testing

Flaxseed Oil, Olive Oil, and Their Combination on Hepatic and Metabolic Outcomes in Patients With Metabolic Dysfunction-Associated Fatty Liver Disease

Who this might be right for
Liver EnzymesGlucose LevelsLipid Profile
University of Lahore 112
Not applicableLooking for participantsNCT07093346
What this trial is testing

The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Nonalcoholic Fatty Liver DiseaseNonalcoholic Fatty Liver Disease (NAFLD)MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease+7 more
University of Nottingham 45
Testing effectiveness (Phase 2)Looking for participantsNCT07198386
What this trial is testing

Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH)

Who this might be right for
NASH
Cascade Pharmaceuticals, Inc 120
Post-approval studies (Phase 4)Study completedNCT02649465
What this trial is testing

SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD

Who this might be right for
Non-alcoholic Fatty Liver Disease
Kanazawa University 40
Not applicableUnknownNCT05120557
What this trial is testing

Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH

Who this might be right for
Liver DiseasesLiver CirrhosisNASH - Nonalcoholic Steatohepatitis+3 more
E-Scopics 1,000
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Post-approval studies (Phase 4)Active Not RecruitingNCT05147090
What this trial is testing

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis bNAFLDCirrhosis+3 more
The University of Hong Kong 106
Large-scale testing (Phase 3)UnknownNCT02530138
What this trial is testing

The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver

Who this might be right for
Non Alcoholic Steatohepatitis
National Nutrition and Food Technology Institute 42
Not applicableStudy completedNCT02231333
What this trial is testing

The Efficacy of S-adenosyl Methionine (SAMe) Versus Pentoxiphylline in Patients With Non-alcoholic Steatohepatitis With Fibrosis

Who this might be right for
Non-alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India 122
Not applicableUnknownNCT02459496
What this trial is testing

Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus

Who this might be right for
Type 2 DiabetesNAFLDObesity+2 more
German Institute of Human Nutrition 200
Testing effectiveness (Phase 2)Study completedNCT03863574
What this trial is testing

Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Zydus Therapeutics Inc. 16
Not applicableStudy completedNCT03233178
What this trial is testing

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
LMC Diabetes & Endocrinology Ltd. 4,000
Next Page